Canada Imports One Million Faulty Respirators from China

Prime Minister Justin Trudeau addresses Canadians on the COVID-19 pandemic from Rideau Cottage in Ottawa on April 16, 2020. Sean Kilpatrick/The Canadian Press

Canadian health officials said that around 1 million KN95 respirators obtained from China failed to meet federal quality standards for use against COVID-19 and so were not distributed to staff on the frontlines of the outbreak.

Eric Morrissette, a spokesperson for the Public Health Agency of Canada (PHAC), said the KN95 masks acquired from China were deemed “unfit” for use and as a result, the federal government was unable to distribute the non-compliant masks to provinces and territories in Canada that are facing shortages amid the pandemic.

“To date, PHAC has identified approximately 1 million KN95 masks as non-compliant with specifications for health care settings,” Morrissette said in a statement, according to Canadian news outlet The Globe and Mail.

Canada’s Department of Health did not indicate whether the government would get a refund for the faulty masks, the report noted.

KN95 masks are a China-made model of the popular N95 mask used to protect frontline medical staff from the Chinese Communist Party (CCP) virus, the novel coronavirus that causes COVID-19.

The Mayor of Jerusalem wears a protective KN95 mask at a testing location for COVID-19 in East Jerusalem on April 2, 2020. Ahmad Gharabli/AFP/Getty Images

According to a report by Politico, Canada relies on China for some 70 percent of its imports of COVID-19 medical supplies.

The United States, too, is vulnerable to disruption of medical supply chains that are rooted in China, though apparently to a somewhat lesser extent. According to an April 6 report from the Congressional Research Service (pdf), U.S. imports from China of pharmaceuticals and medical equipment, products, and supplies amounted to 9.2 percent of all the nation’s imports of such products. America imports more of this category of products from Germany (11.3 percent) and Ireland (15.9 percent).

Still, amid a spike in worldwide demand for such products amid the pandemic, the United States has faced shortages.

“Because of China’s role as a global supplier of PPE, medical devices, antibiotics, and active pharmaceutical ingredients, reduced export from China have led to shortages of critical medical supplies in the United States,” the authors of the report noted.